BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Molecular Biology
Link
http://www.tandfonline.com/doi/pdf/10.4161/epi.22561
Reference28 articles.
1. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome
2. BRCA1 and BRCA2: different roles in a common pathway of genome protection
3. Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
4. Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
5. Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pan-cancer Analysis of Homologous Recombination Deficiency in Cell Lines;2024-05-20
2. Role of Epigenetics for the Efficacy of Cisplatin;International Journal of Molecular Sciences;2024-01-17
3. Epigenetic biomarkers in personalized medicine;Personalized Epigenetics;2024
4. Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer;Journal of Cancer Research and Clinical Oncology;2023-07-07
5. Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape;Cancers;2023-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3